Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 379845, 7 pages
http://dx.doi.org/10.1155/2012/379845
Research Article

Control and Augmentation of Long-Term Plasmid Transgene Expression In Vivo in Murine Muscle Tissue and Ex Vivo in Patient Mesenchymal Tissue

Cork Cancer Research Centre, BioSciences Institute, University College Cork, Cork, Ireland

Received 28 January 2012; Revised 7 April 2012; Accepted 13 April 2012

Academic Editor: Claude Bagnis

Copyright © 2012 David Morrissey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. Evans, “Orthopaedics: gene therapy's dark horse,” Gene Therapy, vol. 11, no. 4, p. 343, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Hannallah, B. Peterson, J. R. Lieberman, F. H. Fu, and J. Huard, “Gene therapy in orthopaedic surgery,” Instructional Course Lectures, vol. 52, pp. 753–768, 2003. View at Google Scholar · View at Scopus
  3. K. Hildebrand and C. Frank, “Ligaments: structure, function and response to injury and repairin,” in Principles of Orthopaedic Practice, R. Dee et al., Ed., pp. 109–117, McGraw-Hill, New York, NY, USA, 1997. View at Google Scholar
  4. P. Kloen, M. Di Paola, O. Borens et al., “BMP signaling components are expressed in human fracture callus,” Bone, vol. 33, no. 3, pp. 362–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Bolt, A. N. Clerk, H. H. Luu et al., “BMP-14 gene therapy increases tendon tensile strength in a rat model of achilles tendon injury,” Journal of Bone and Joint Surgery—Series A, vol. 89, no. 6, pp. 1315–1320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. W. A. Baltzer, C. Lattermann, J. D. Whalen et al., “Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene,” Gene Therapy, vol. 7, no. 9, pp. 734–739, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Gouze, J. N. Gouze, G. D. Palmer, C. Pilapil, C. H. Evans, and S. C. Ghivizzani, “Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases,” Molecular Therapy, vol. 15, no. 6, pp. 1114–1120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Zaiss and D. A. Muruve, “Immunity to adeno-associated virus vectors in animals and humans: a continued challenge,” Gene Therapy, vol. 15, no. 11, pp. 808–816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Donsante, D. G. Miller, Y. Li et al., “AAV vector integration sites in mouse hepatocellular carcinoma,” Science, vol. 317, no. 5837, p. 477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Brooks, R. N. Harkins, P. Wang, H. S. Qian, P. Liu, and G. M. Rubanyi, “Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle,” Journal of Gene Medicine, vol. 6, no. 4, pp. 395–404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Fang et al., “Stimulation of new bone formation by direct transfer of osteogenic plasmid genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 12, pp. 5753–5758, 1996. View at Google Scholar
  12. G. A. Rao and D. D. Buethe, “Plasmid based gene delivery for orthopedic disorders: a brief review,” Journal of Drug Targeting, vol. 12, no. 6, pp. 341–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. N. Waddington, J. H. McVey, D. Bhella et al., “Adenovirus serotype 5 hexon mediates liver gene transfer,” Cell, vol. 132, no. 3, pp. 397–409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Rajendran, D. O'Hanlon, D. Morrissey, T. O'Donovan, G. C. O'Sullivan, and M. Tangney, “Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer,” Experimental Biology and Medicine, vol. 236, no. 4, pp. 423–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Wolff, R. W. Malone, P. Williams et al., “Direct gene transfer into mouse muscle in vivo,” Science, vol. 247, no. 4949, pp. 1465–1468, 1990. View at Google Scholar · View at Scopus
  16. D. Sheyn, N. Kimelman-Bleich, G. Pelled, Y. Zilberman, D. Gazit, and Z. Gazit, “Ultrasound-based nonviral gene delivery induces bone formation in vivo,” Gene Therapy, vol. 15, no. 4, pp. 257–266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Wu, G. Sundaresan, M. Iyer, and S. S. Gambhir, “Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice,” Molecular Therapy, vol. 4, no. 4, pp. 297–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. O. B. Betz, V. M. Betz, A. Nazarian et al., “Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects,” Gene Therapy, vol. 14, no. 13, pp. 1039–1044, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Ratanamart, C. G. Huggins, and J. A. M. Shaw, “Transgene expression in mononuclear muscle cells not infiltrating inflammatory cells following intramuscular plasmid gene electrotransfer,” Journal of Gene Medicine, vol. 12, no. 4, pp. 377–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Brower and N. M. Vickroy, “A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5,” Spine, vol. 33, no. 18, pp. E653–E655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Gould, N. Yousaf, R. Fatah, M. C. Subang, and Y. Chernajovsky, “Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis,” Arthritis Research and Therapy, vol. 9, article R7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Abe, M. Yamamoto, Y. Taguchi et al., “Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin,” Journal of Bone and Mineral Research, vol. 15, no. 4, pp. 663–673, 2000. View at Google Scholar · View at Scopus
  23. L. M. Golub, K. Suomalainen, and T. Sorsa, “Host modulation with tetracyclines and their chemically modified analogues,” Current Opinion in Dentistry, vol. 2, pp. 80–90, 1992. View at Google Scholar · View at Scopus
  24. A. F. Steinert, M. Weber, M. Kunz et al., “In situ IGF-1 gene delivery to cells emerging from the injured anterior cruciate ligament,” Biomaterials, vol. 29, no. 7, pp. 904–916, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Rajendran, S. Salwa, X. Gao et al., “Ex Vivo culture of patient tissue & examination of gene delivery,” Journal of Visualized Experiments, no. 46, Article ID e2378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Tangney and K. P. Francis, “In vivo optical imaging in gene & cell therapy,” Current Gene Therapy, vol. 12, no. 1, pp. 2–11, 2012. View at Google Scholar · View at Scopus
  27. S. A. Collins, K. Hiraoka, A. Inagaki, N. Kasahara, and M. Tangney, “Pet imaging for gene & cell therapy,” Current Gene Therapy, vol. 12, no. 1, pp. 20–32, 2012. View at Google Scholar · View at Scopus